Pictet Asset Management Holding Sa Immunocore Holdings PLC Transaction History

Pictet Asset Management Holding Sa

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$60.14 - $75.36 $6.19 Million - $7.76 Million	-103,000 Reduced 12.72%	706,607 $45.9 Million
Q4 2023 Feb 13, 2024	SELL	$42.85 - $69.5 $4.31 Million - $6.99 Million	-100,631 Reduced 11.06%	809,607 $55.3 Million
Q3 2023 Nov 14, 2023	BUY	$49.5 - $66.6 $45.1 Million - $60.6 Million	910,238 New	910,238 $47.2 Million

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet Asset Management Holding Sa with notifications on news.